AVEO stock forecast
Our latest prediction for AVEO Pharmaceuticals, Inc.'s stock price was made on the April 8, 2019 when the stock price was at 1.10$.
In the short term (2weeks), AVEO's stock price should outperform the market by 6.57%. During that period the price should oscillate between -11.83% and +38.19%.
In the medium term (3months), AVEO's stock price should outperform the market by 10.58%. During that period the price should oscillate between -23.48% and +92.77%.Get email alerts
About AVEO Pharmaceuticals, Inc.
AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA.
At the moment the company generates 30M USD in revenues.
On its last earning announcement, the company reported a profit of 0.13$ per share.
The book value per share is -0.38$
Three months stock forecastApril 8, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|